Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure

Background: Welding exposes workers to manganese (Mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes individuals to develop parkinsonism. PET imaging with 6-[18F]fluoro-l-dopa (FDOPA) is a noninvasive measure of nigrostriatal dopaminergic neuron integrity. The purpose of this study is to determine whether welding exposure is associated with damage to nigrostriatal neurons in asymptomatic workers. Methods: We imaged 20 asymptomatic welders exposed to Mn fumes, 20 subjects with idiopathic Parkinson disease (IPD), and 20 normal controls using FDOPA PET. All subjects were examined by a movement disorders specialist. Basal ganglia volumes of interest were identified for each subject. The specific uptake of FDOPA, Ki, was generated for each region using graphical analysis method. Results: Repeated measures general linear model (GLM) analysis demonstrated a strong interaction between diagnostic group and region (F4,112 = 15.36, p < 0.001). Caudate Kis were lower in asymptomatic welders (0.0098 + 0.0013 minutes−1) compared to control subjects (0.0111 + 0.0012 minutes−1, p = 0.002). The regional pattern of uptake in welders was most affected in the caudate > anterior putamen > posterior putamen. This uptake pattern was anatomically reversed from the pattern found in subjects with IPD. Conclusions: Active, asymptomatic welders with Mn exposure demonstrate reduced FDOPA PET uptake indicating dysfunction in the nigrostriatal dopamine system. The caudate Ki reduction in welders may represent an early (asymptomatic) marker of Mn neurotoxicity and appears to be distinct from the pattern of dysfunction found in symptomatic IPD.

[1]  W. Martin,et al.  Quantitative estimation of regional brain iron with magnetic resonance imaging. , 2009, Parkinsonism & related disorders.

[2]  M. Aschner,et al.  Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  N. Seixas,et al.  Validity and Reliability of an Occupational Exposure Questionnaire for Parkinsonism in Welders , 2009, Journal of occupational and environmental hygiene.

[4]  L. Pham,et al.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism , 2008, Journal of neurochemistry.

[5]  Neurobiology in Ageing Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study , 2008 .

[6]  Pam Susi,et al.  Manganese and Welding Fume Exposure and Control in Construction , 2007, Journal of occupational and environmental hygiene.

[7]  Maryse Bouchard,et al.  Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. , 2007, Neurotoxicology.

[8]  T. Guilarte,et al.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.

[9]  Alexander Storch,et al.  Early diagnosis of Parkinson’s disease , 2006, Journal of Neurology.

[10]  T. Videen,et al.  [18F]FDOPA PET and clinical features in parkinsonism due to manganism , 2005, Movement disorders : official journal of the Movement Disorder Society.

[11]  Wei Zheng,et al.  Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. , 2005, Neurotoxicology.

[12]  W. Heiss,et al.  The sensitivity of 18‐fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease , 2004, European journal of neurology.

[13]  J. Antonini,et al.  Health Effects of Welding , 2003, Critical reviews in toxicology.

[14]  Karl Herholz,et al.  The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans , 2002, Neuroscience Letters.

[15]  J. Langston,et al.  Novel observations with FDOPA‐PET imaging after early nigrostriatal damage , 2001, Movement disorders : official journal of the Movement Disorder Society.

[16]  S Fahn,et al.  Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .

[17]  J. Farrar,et al.  Welding-related parkinsonism: clinical features, treatment, and pathophysiology. , 2001, Neurology.

[18]  R E Korczynski,et al.  Occupational health concerns in the welding industry. , 2000, Applied occupational and environmental hygiene.

[19]  J O Rinne,et al.  Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. , 2000, Archives of neurology.

[20]  P Susi,et al.  The use of a task-based exposure assessment model (T-BEAM) for assessment of metal fume exposures during welding and thermal cutting. , 2000, Applied occupational and environmental hygiene.

[21]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[22]  J. W. Kim,et al.  Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. , 1999, Neurotoxicology.

[23]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[24]  S. Kish,et al.  Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations , 1998, Annals of neurology.

[25]  Jesper L. R. Andersson,et al.  How to obtain high-accuracy image registration: application to movement correction of dynamic positron emission tomography data , 1998, European Journal of Nuclear Medicine.

[26]  K. Marder,et al.  Altered systemic iron metabolism in Parkinson's disease , 1997, Neurology.

[27]  B. Snow,et al.  Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication , 1997, Neurology.

[28]  D J Burn,et al.  Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study , 1997, Annals of neurology.

[29]  R. Butterworth,et al.  Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms , 1996, Hepatology.

[30]  C. Marsden,et al.  The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.

[31]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[32]  Richard S. J. Frackowiak,et al.  The identification of presymptomatic parkinsonism: Clinical and {18F}dopa positron emission tomography studies in an irish kindred , 1992, Annals of neurology.

[33]  J. Mazziotta,et al.  Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.

[34]  W T Yuh,et al.  Neoplastic vs Inflammatory Meningeal Enhancement with Gd‐DTPA , 1990, Journal of computer assisted tomography.

[35]  N. Chu,et al.  Positron emission tomography in manganese intoxication , 1989, Annals of neurology.

[36]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[37]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[38]  J RODIER,et al.  Manganese Poisoning in Moroccan Miners , 1955, British journal of industrial medicine.